VanEck Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,418	Closed	-$10K	–	1457
2022 Q4	$10K	Buy	11,418 +4,130	+57%	+$3.62K	﹤0.01%	1374
2022 Q3	$11K	Buy	+7,288	New	+$11K	﹤0.01%	1337